Tag: Therapeutic apheresis

Therapeutic plasma exchange (TPE) is widely used to treat various antibody-mediated conditions, with the choice of replacement fluid being a critical factor in the treatment's outcome. In pharmacology, understanding **what are the substitution fluids for plasma exchange?** is essential for determining the appropriate treatment strategy and managing patient risks during this vital medical procedure.

The most frequent adverse event reported by donors and patients undergoing apheresis is a transient tingling or numbness, a mild form of citrate toxicity which is the most common side effect of apheresis. This reaction is caused by the anticoagulant used during the procedure and is typically managed quickly and effectively by the medical staff.